Bing

Although stock market corrections are a perfectly normal and healthy ... La Jolla Pharmaceutical (NASDAQ: LJPC) La Jolla Pharmaceutical, which had also been written off by investors until recently, is a wholly …
The Motley Fool · BySean Williams · 8/28/2015
La Jolla Pharmaceutical Company (NASDAQ:LJPC) Director Kevin C. Tang purchased 170,000 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was bought at an average price of $27.
Ticker Report · 8/22/2015
La Jolla Pharmaceutical Company (NASDAQ:LJPC) Director Kevin C. Tang acquired 170,000 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was purchased at an average price of $27.11 per share, for a total ...
sleekmoney.com · 8/22/2015
More from Bing News
Macrocure Ltd. (MCUR) traded at $4.52 + 1.54 (51.64 pct) on 6,245,524 total stock volume. The company is -38.10 pct year-to-date, and -51.79 pct over the last 12 months. La Jolla Pharma LJPC) traded at $30.78 + 4.
Fx Pips · 8/25/2015
ALSO READ: 10 Stocks That Have Ignored the Recent Massive Sell-Off These companies also reported insider buying this week: La Jolla Pharmaceutical Co. (NASDAQ: LJPC), MasTec Inc. (NYSE: MTZ), MPLX L.P.
24/7 Wall ST · 1 day ago
insider buying
La Jolla Pharmaceutical Company (NASDAQ:LJPC) Director Kevin C. Tang purchased 170,000 shares of the stock in a transaction dated Friday, August 21st. The stock was acquired at an average cost of $27.11 per share, for a total transaction of $4,608 …
wkrb13.com · 8/22/2015
La Jolla Pharmaceutical Co. (LJPC - Snapshot Report) was a big mover last session, as the company saw its shares surge nearly 11% on the day. This led to far more shares changing hands than in a normal session. This continues the most recent …
ZACKS · 6/1/2015
On August 19, 2015, La Jolla Pharmaceutical Company (the "Company") held its 2015 Annual Meeting ... Incentive Plan (the "Plan") to increase the number of shares of common stock authorized for issuance thereunder. The amendment to the Plan was …
4 Traders · 8/25/2015
Explore the tool here. Article printed from InvestorPlace Media, http://investorplace.com/2015/08/6-biotechnology-stocks-to-buy-now-ljpc-incy-ambi-3/.
Investor Place · 8/5/2015
La Jolla Pharmaceutical Company (NASDAQ:LJPC) Director Kevin C. Tang purchased 190,583 shares of La Jolla Pharmaceutical Company stock on the open market in a transaction dated Wednesday, May 13th. The shares were purchased at an average …
Mideast Times · 5/14/2015